Siren L.L.C. Trims Holdings in Seer, Inc. $SEER

Siren L.L.C. decreased its position in shares of Seer, Inc. (NASDAQ:SEER) by 38.5% in the first quarter, HoldingsChannel reports. The firm owned 2,458,673 shares of the company’s stock after selling 1,541,327 shares during the quarter. Siren L.L.C.’s holdings in Seer were worth $4,131,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of SEER. Nano Cap New Millennium Growth Fund L P acquired a new stake in shares of Seer in the 4th quarter valued at about $1,510,000. Goldman Sachs Group Inc. boosted its position in shares of Seer by 13.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 211,053 shares of the company’s stock worth $386,000 after buying an additional 24,240 shares during the period. Susquehanna International Group LLP boosted its position in shares of Seer by 22.8% during the third quarter. Susquehanna International Group LLP now owns 123,447 shares of the company’s stock worth $268,000 after buying an additional 22,918 shares during the period. Shay Capital LLC grew its holdings in shares of Seer by 17.7% during the third quarter. Shay Capital LLC now owns 73,571 shares of the company’s stock worth $160,000 after buying an additional 11,073 shares in the last quarter. Finally, Squarepoint Ops LLC grew its holdings in shares of Seer by 57.0% during the third quarter. Squarepoint Ops LLC now owns 91,906 shares of the company’s stock worth $199,000 after buying an additional 33,349 shares in the last quarter. Hedge funds and other institutional investors own 75.20% of the company’s stock.

Analysts Set New Price Targets

SEER has been the topic of several research reports. TD Cowen upgraded Seer to a “strong-buy” rating in a research note on Monday, April 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Seer in a research note on Friday, July 17th. Finally, Canaccord Genuity Group began coverage on shares of Seer in a report on Monday, May 4th. They issued a “buy” rating and a $4.00 price objective on the stock. Two investment analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $4.00.

Seer Price Performance

Seer stock opened at $2.05 on Friday. The company has a market cap of $112.71 million, a price-to-earnings ratio of -1.65 and a beta of 1.59. The firm has a 50-day moving average of $1.86 and a 200-day moving average of $1.86. Seer, Inc. has a one year low of $1.55 and a one year high of $2.41.

Seer (NASDAQ:SEER) last released its earnings results on Wednesday, May 13th. The company reported ($0.30) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.30). Seer had a negative return on equity of 26.58% and a negative net margin of 464.78%.The business had revenue of $2.79 million for the quarter, compared to the consensus estimate of $3.60 million.

Seer Company Profile

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.